CHAMPIONS ONCOLOGY, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of -528.00% for the 12-month period ending 2018-04-30, per its 10-K filed 2018-07-30.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2018-07-30
- CHAMPIONS ONCOLOGY, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2018 was -528.00%, a 105700.00% decline from fiscal 2017.
- CHAMPIONS ONCOLOGY, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2017 was 0.50%, a 77.27% decline from fiscal 2016.
- CHAMPIONS ONCOLOGY, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2016 was 2.20%.
- CHAMPIONS ONCOLOGY, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2015 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month |
|---|---|
| 2018-04-30 | -528.00% 10-K · filed 2018-07-30 |
| 2017-04-30 | 0.50% 10-K · filed 2018-07-30 |
| 2016-04-30 | 2.20% 10-K · filed 2017-07-28 |
| 2015-04-30 | 0.00% 10-K · filed 2016-07-29 |
| 2014-04-30 | -1.40% 10-K · filed 2015-07-29 |
| 2013-04-30 | 1.70% 10-K · filed 2014-07-28 |
| 2012-04-30 | -2.90% 10-K · filed 2013-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |